A detailed history of Steph & CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Steph & CO holds 80 shares of BDX stock, worth $18,279. This represents 0.01% of its overall portfolio holdings.

Number of Shares
80
Previous 47 70.21%
Holding current value
$18,279
Previous $10,000 90.0%
% of portfolio
0.01%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$221.47 - $242.41 $7,308 - $7,999
33 Added 70.21%
80 $19,000
Q2 2024

Jul 30, 2024

BUY
$225.07 - $246.17 $900 - $984
4 Added 9.3%
47 $10,000
Q1 2024

Apr 12, 2024

BUY
$233.45 - $247.73 $10,038 - $10,652
43 New
43 $10,000
Q3 2023

Oct 26, 2023

BUY
$254.9 - $283.59 $13,509 - $15,030
53 New
53 $13,000
Q2 2022

Jul 13, 2022

SELL
$234.74 - $275.42 $10,563 - $12,393
-45 Closed
0 $0
Q4 2021

Jan 24, 2022

BUY
$230.08 - $250.94 $10,353 - $11,292
45 New
45 $11,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Steph & CO Portfolio

Follow Steph & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steph & CO, based on Form 13F filings with the SEC.

News

Stay updated on Steph & CO with notifications on news.